DMAA
Drugs Made In America Acquisition Corp (DMAA)
Financial Services • NASDAQ • $10.600.00%
Key Fundamentals
- Symbol
- DMAA
- Exchange
- NASDAQ
- Sector
- Financial Services
- Industry
- Shell Companies
- Price
- $10.60
- Daily Change
- 0.00%
- Market Cap
- $357.40M
- Trailing P/E
- 55.79
- Forward P/E
- N/A
- 52W High
- $10.60
- 52W Low
- $10.09
- Analyst Target
- N/A
- Dividend Yield
- N/A
- Beta
- N/A
About Drugs Made In America Acquisition Corp
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in Fort Lauderdale, Florida.
Company websiteResearch DMAA on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.